Vivos Inc (RDGL)

[DreDiZzlE]

Vet market is BS. Not profitable. Only popped up to help boost the pps becasue the company cant afford human clinical trials for the human market.

Ask the company for a breakdown of how the margins will work. The profit margins are not there...

Heres real figures. ..

jim estimated in the 10q 5-10 MILLION price tag for radiogel manufacturing. If this figure is different for animal market the company insiders should show the difference in manufacturing costs.

The manufacturing can't be cheap because amiC is NOT ALLOWED PER THE FDA TO MAKE RADIOGEL AT THEIR OWN LOCATION BECAUSE ITS NOT UP TO THE REUQIRED STANDARDS like stated in the documentation below, and the cost of using a company to outsource the manufacturing is high as shown below also:


THE COMPANY IS NOT ALLOWED CURRENTLY TO MAKE THEIR OWN PRODUCT AT THEIR OWN LOCATION AND ISO FEES ARE MORE THAN $250K but not sure how high for their current work.

Dr. Fisher estimated the cost of treating cats in this document :




**Jims estimate of 5-10 million price tag for radiogel manufacturing.

**dr. Fisher cat care estimate

** amic not allowed to make their own product at their own site required currently to outsource manufacturing at high cost.

*can radiogel be produced in very small batches and be profitable? Or would it only be profitable if the vet lady has orders stacked up which looks tough from the cost estimate.

Thats what's on paper.

Animal market only popping up because of these discrepancies about the human market :

Denovo submission will not work. Fda will not approve. Documents show the truth.

@solarwolfenergy Human trials have NOT been requested. We are working with the FDA closely. Phase I animal trials already completed - AMIC

— RadioGel™ (@RadioGel) December 19, 2015

"Human trials have NOT been requested".

-james katzaroff

•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••


"The FDA REQUESTED additional clinical studies in BOTH animal and human subjects. We believe that this response clearly supports the concept of widespread clinical use in both veterinary and human cancer patients."

--Dr. FISHER (govt agency document)

"REQUESTED"

-"CLINICAL STUDIES IN BOTH ANIMAL AND HUMAN"-